Advertisement
Singapore markets closed

  • Straits Times Index

    3,300.00
    -4.00 (-0.12%)
     

  • S&P 500

    5,487.03
    +13.80 (+0.25%)
     

  • Dow

    38,834.86
    +56.76 (+0.15%)
     

  • Nasdaq

    17,862.23
    +5.21 (+0.03%)
     

  • Bitcoin USD

    66,059.83
    +854.41 (+1.31%)
     

  • CMC Crypto 200

    1,374.66
    -8.00 (-0.58%)
     

  • FTSE 100

    8,230.86
    +25.75 (+0.31%)
     

  • Gold

    2,353.00
    +6.10 (+0.26%)
     

  • Crude Oil

    81.73
    +0.16 (+0.20%)
     

  • 10-Yr Bond

    4.2170
    0.0000 (0.00%)
     

  • Nikkei

    38,633.02
    +62.26 (+0.16%)
     

  • Hang Seng

    18,335.32
    -95.07 (-0.52%)
     

  • FTSE Bursa Malaysia

    1,592.69
    -7.10 (-0.44%)
     

  • Jakarta Composite Index

    6,819.32
    +92.40 (+1.37%)
     

  • PSE Index

    6,344.56
    -21.47 (-0.34%)
     

Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Business Wire
·1-min read

AUSTIN, Texas, June 03, 2024--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 7:40 a.m. PT (10:40 a.m. ET).

A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

ADVERTISEMENT

View source version on businesswire.com: https://www.businesswire.com/news/home/20240603615720/en/

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com
Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com